Abstract
The Deleted in Colorectal Cancer gene (DCC) encodes a cell surface receptor that belongs to the Ig superfamily. Inactivation of the DCC gene has been implicated in human tumor progression. However, little is known about the biological function of the DCC protein. In the present study, we demonstrated that expression of DCC activated caspase-3 and programmed cell death, or induced G2/M cell cycle arrest in tumor cells. In some cell lines, apoptosis was evident within 24 h of DCC expression. Timing of the appearance of apoptotic cells coincided with that of the cleavage of poly (ADP-ribose) polymerase, a substrate of caspase-3. Expression of the apoptosis inhibitory gene Bcl-2 was not able to abrogate the DCC-induced apoptosis. In the G2/M cycle arrest cells, cdk1 activity was inhibited. Our results suggest that the DCC protein may transduce signals resulting in activation of caspases or inhibition of Cdk1. These data provide a possible mechanism by which DCC suppresses tumorigenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- Cdk:
-
cyclin-dependent kinase
- DAPI:
-
4′, 6-Diamidine-2′-Phenylindole Dihydrochloride
- DMEM:
-
Dulbecco modified minimum essential medium
- EGF:
-
epidermal growth factor
- Ig:
-
immunoglobulin
- MOI:
-
multiplicity of infection
- FBS:
-
fetal bovine serum
- PARP:
-
poly (ADP-ribose) polymerase
References
Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G and Thompson CB. . 1993 Cell 74: 597–608.
Chan SSY, Zheng H, Su MW, Wilk R, Killeen MT, Hedgecock EM and Culotti JG. . 1996 Cell 87: 187–195.
Chen YQ, Gao X, Grignon D, Sarkar F, Sakr W, Cipriano SC, Honn KV, Borders J and Crissman J. . 1994 Cancer Molec. Biol. 1: 357–367.
Chen YQ, Cipriano SC, Arenkiel JM and Miller FR. . 1995 Cancer Res. 55: 4536–4539.
Cho KR, Oliner JD, Simons JW, Hedrick L, Fearon ER, Preisinger AC, Hedge P, Silverman GA and Volgestein B. . 1994 Genomics 19: 525–531.
Cipriano SC and Chen YQ. . 1998 Oncogene 17: 1549–1556.
Cleveland JL and Ihle JN. . 1995 Cell 81: 479–482.
Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery Jr CA, Butel JS and Bradley A. . 1992 Nature 356: 215–221.
Dunphy WG. . 1994 Trends Cell Biol. 4: 202–207.
Fazeli A, Dickinson SL, Hermiston ML, Tighe RV, Steen RG, Small CG, Stoeckli ET, Keino-Masu K, Masu M, Rayburn H, Simons J, Bronson RT, Gordon JI, Tessier-Lavigne M and Weinberg RA. . 1997 Nature 386: 796–804.
Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, Hamilton SR, Preisinger AC, Thomas G, Kinzler KW and Vogelstein B. . 1990 Science 247: 49–56.
Fearon ER. . 1996 Biochim. Biophy. Acta. 1288: 17–23.
Fraser A and Evan G. . 1996 Cell 85: 781–784.
Gao X, Honn K, Grignon D, Sakr W and Chen YQ. . 1993 Cancer Res. 53: 2723–2727.
Hakem R, de la Pompa JL, Sirard C, Mo R, Woo M, Hakem A, Wakeham A, Potter J, Reitmair A, Billia F, Firpo E, Hui CC, Roberts J, Rossant J and Mak TW. . 1996 Cell 85: 1009–1023.
Haldar S, Chintapalli J and Croce CM. . 1996 Cancer Res. 56: 1253–1255.
Hedrick L, Cho KR, Boyd J, Risinger J and Vogelstein B. . 1992 Cold Spring Harbor Sym. Quant. Bio. 57: 345–351.
Hunter T and Pines J. . 1994 Cell 79: 573–582.
Jones N and Shenk T. . 1979 Cell 17: 683–689.
Kaufman SH, Desnoyers S, Ottaviano Y, Davidson NE and Poirier GG. . 1993 Cancer Res. 53: 3976–3985.
Keino-Masu K, Masu M, Hinck L, Leonardo ED, Chan SSY, Culotti JG and Tessier-Lavigne M. . 1996 Cell 87: 175–185.
King RW, Jackson PK and Kirschner MW. . 1994 Cell 79: 563–571.
Kleinerman DI, Zhang WW, Lin SH, Van NT, von Eschenbach AC and Hsieh JT. . 1995 Cancer Res. 55: 2831–2836.
Kolodziej PA, Timpe LC, Mitchell KJ, Fried SR, Goodman CS, Jan LY and Jan YN. . 1996 Cell 87: 197–204.
Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG and Earnshaw WC. . 1994 Nature 371: 346–347.
Liu CY, Flesken-Nikitin A, Li S, Zeng Y and Lee WH. . 1996 Genes Dev. 10: 1835–1843.
Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin TT, Yu VL and Miller DK. . 1995 Nature 376: 37–43.
Nurse P. . 1994 Cell 79: 547–550.
Oltvai ZN and Korsmeyer SJ. . 1994 Cell 79: 189–192.
Sharan SK, Morimatsu M, Albrecht U, Lim D, Regel E, Dinh C, Sands A, Eichele G, Hasty P and Bradley A. . 1997 Nature 386: 804–810.
Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS and Dixit VM. . 1995 Cell 81: 801–809.
Thiagalingam S, Lengauer C, Leach FS, Schutte M, Hahn SA, Overhauser J, Wilson JKV, Markowitz S, Hamilton SR, Kern SE, Kinzler KW and Vogelstein B. . 1996 Nature Genetics 13: 343–346.
White E. . 1996 Genes Dev. 10: 1–15.
Acknowledgements
We would like to thank Drs Bert Vogelstein, Kathy Cho and Lora Hedrick (Johns Hopkins University) for DCC cDNA, Dr Marc Tessier-Lavigne (UCSF) for netrin-1 protein, Dr Gabriel Nunez (University of Michigan) for SHEP-1neo, SHEP-1Bcl-2, SHEP-1BclxL cells and pcDNA Bcl-2-flag vector, Dr Isabelle Berquin (University of Michigan) for critical reading the manuscript and Ms Pan Tabasca (Wayne State University) for performing flow cytometry analysis. This study is partially supported by R21CA69845, DAMD 17-98-1-8501 (YQC) and R01CA73017 (JTH).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chen, Y., Hsieh, JT., Yao, F. et al. Induction of apoptosis and G2/M cell cycle arrest by DCC. Oncogene 18, 2747–2754 (1999). https://doi.org/10.1038/sj.onc.1202629
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202629
Keywords
This article is cited by
-
Somatic mutations in DCC are associated with genomic instability and favourable outcomes in melanoma patients treated with immune checkpoint inhibitors
British Journal of Cancer (2022)
-
CHD8 safeguards early neuroectoderm differentiation in human ESCs and protects from apoptosis during neurogenesis
Cell Death & Disease (2021)
-
Calcium, a Cell Cycle Commander, Drives Colon Cancer Cell Diffpoptosis
Indian Journal of Clinical Biochemistry (2017)
-
Deficiency of APPL1 in mice impairs glucose-stimulated insulin secretion through inhibition of pancreatic beta cell mitochondrial function
Diabetologia (2013)
-
Dependence receptors: a new paradigm in cell signaling and cancer therapy
Oncogene (2010)